Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$3.53 - $12.21 $70,600 - $244,200
-20,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$11.58 - $17.37 $231,600 - $347,400
-20,000 Reduced 50.0%
20,000 $243,000
Q2 2019

Aug 15, 2019

BUY
$13.19 - $28.36 $527,600 - $1.13 Million
40,000 New
40,000 $585,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Lee Capital Holdings LLC Portfolio

Follow Lee Capital Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Capital Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lee Capital Holdings LLC with notifications on news.